COVID-19Ministry of Health and Family WelfareHealthIndia

India’s Cumulative COVID-19 Vaccination Coverage exceeds 178.29 Cr

More than 24.84 lakh Vaccine Doses administered in the last 24 hours

Recovery Rate currently stands at 98.64%

6,396 New Cases reported in the last 24 hours

India’s Active Caseload currently stands at 69,897

Weekly Positivity Rate is presently at 0.90%

With the administration of more than 24.84 lakh Doses (24,84,412) vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 178.29 Cr (1,78,29,13,060) as per provisional reports till 7 am today.

This has been achieved through 2,06,05,684 sessions. The break-up of the cumulative figure as per the provisional report till 7 am today include:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,04,01,859
2nd Dose 99,71,780
Precaution Dose 42,14,216
FLWs 1st Dose 1,84,10,046
2nd Dose 1,74,51,962
Precaution Dose 63,12,690
Age Group 15-18 years 1st Dose 5,51,46,865
2nd Dose 2,94,46,462
Age Group 18-44 years 1st Dose 55,22,22,294
2nd Dose 44,72,33,716
Age Group 45-59 years 1st Dose 20,23,40,255
2nd Dose 18,08,32,789
Over 60 years 1st Dose 12,64,67,129
2nd Dose 11,26,18,005
Precaution Dose 98,42,992
Precaution Dose 2,03,69,898
Total 1,78,29,13,060

 

13,450 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,23,67,070.

Consequently, India’s recovery rate stands at 98.64%.

6,396 new cases were reported in the last 24 hours.

India’s Active Caseload is presently at 69,897. Active cases constitute 0.16% of the country’s total Positive Cases.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 9,23,351 tests being conducted. India has so far conducted over 77.09 Cr (77,09,73,356) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate in the country currently stands at 0.90% and the Daily Positivity rate is reported to be 0.69%.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker